BDBM419533 US10457703, Example 195::US10457703, Example 196

SMILES CC[C@H]1[C@@H](O)[C@H]2[C@@H]3CC[C@H]([C@H](C)CCOC(=O)NC4CCCC4O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CC[C@@H](O)C[C@@H]12

InChI Key InChIKey=FYANNSNROLCVIC-SUWJCSNTSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 419533   

TargetBile acid receptor(Homo sapiens (Human))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM419533(US10457703, Example 195 | US10457703, Example 196)
Affinity DataEC50: <10nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBile acid receptor(Homo sapiens (Human))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM419533(US10457703, Example 195 | US10457703, Example 196)
Affinity DataEC50: <10nMAssay Description:Determination of a ligand mediated Gal4 promoter driven transactivation to quantify ligand binding mediated activation of FXR. FXR Reporter Assay kit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent